ANEB
ANEBULO PHARMACEUTICALS, INC.Marquee-fund ownership over time
This quarter's activity
New positions opened
None.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Citadel Advisors 2× in & out | Q1 2026 | Q2 2026 | → $0.46 | -4% |
| Renaissance Technologies | Q4 2025 | Q2 2026 | → $0.46 | -81% |
| Millennium Management | Q2 2025 | Q4 2025 | → $2.28 | +126% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Anebulo Pharmaceuticals, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Apr 7, 2025 — the most recent Form 4 on file — not from today.
- Form 40001641172-25-003093Apr 7, 2025
- Form 40001641172-25-003089Apr 7, 2025
- Form 40001641172-25-003090Apr 7, 2025
- Form 40001641172-25-003092Apr 7, 2025
- Form 40001641172-25-003095Apr 7, 2025
- Form 40001641172-25-003091Apr 7, 2025
- Form 40001641172-25-003088Apr 7, 2025
- Form 40001641172-25-003094Apr 7, 2025
- Form 40001641172-25-003087Apr 7, 2025
- Form 40001493152-24-052101Dec 26, 2024
- Form 40001493152-24-049381Dec 10, 2024
- Form 40001493152-24-024125Jun 17, 2024
- Form 40001493152-24-024126Jun 17, 2024
- Form 40001493152-24-024120Jun 17, 2024
- Form 40001493152-24-024124Jun 17, 2024
Fundamentals
XBRL · ANEBULO PHARMACEUTICALS, INC.Annual figures sourced directly from ANEBULO PHARMACEUTICALS, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Anebulo Pharmaceuticals, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 10-QQuarterly reportFeb 12, 2026
- 8-KMaterial eventFeb 12, 2026
- 8-KMaterial eventFeb 6, 2026
- 8-KMaterial eventJan 29, 2026
- 8-KMaterial eventJan 27, 2026
- 8-KMaterial eventDec 22, 2025
- 10-QQuarterly reportNov 13, 2025
- 8-KMaterial eventNov 13, 2025
- 10-KAnnual reportSep 29, 2025
- 8-KMaterial eventSep 29, 2025
- 8-KMaterial eventSep 12, 2025
- 8-KMaterial eventJul 23, 2025
- 10-QFORM 10-QMay 13, 2025
- 8-KMaterial eventMay 13, 2025
- 8-KMaterial eventApr 15, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q1 2026 | Q2 2026 | $0.48 | $0.46 | -4% |
| Renaissance Technologies | Q4 2025 | Q2 2026 | $2.37 | $0.46 | -81% |
| Citadel Advisors | Q2 2025 | Q4 2025 | $1.01 | $2.28 | +126% |
| Millennium Management | Q2 2025 | Q4 2025 | $1.01 | $2.28 | +126% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.